Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

19 ta ish

Ish: The edible tomato COVID-19 vaccine, TOMAVAC, induces neutralising IgGs

  1. Profiling of the most reliable mutations from sequenced SARS-CoV-2 genomes scattered in Uzbekistan

    Mirzakamol S. Ayubov, Zabardast T. Buriev, Mukhammadjon K. Mirzakhmedov +5

    MaqolaOchiq kirishSARS-CoV-2 and COVID-19 ResearchPLoS ONE202210 iqtibos
    ABI

  2. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

    Lianpan Dai, Tianyi Zheng, Kun Xu +18

    MaqolaOchiq kirish20208 iqtibos
    ABI

  3. Sarlavhasiz

    Boshqa8 iqtibos
    ABI

  4. Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults

    Lianpan Dai, Lidong Gao, Lifeng Tao +27

    MaqolaOchiq kirish20227 iqtibos
    ABI

  5. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

    Shilong Yang, Yan Li, Lianpan Dai +26

    MaqolaOchiq kirish20216 iqtibos
    ABI

  6. Covid‐19 vaccines and variants of concern: A review

    Ikbel Hadj Hassine

    Sharh maqolaOchiq kirish20215 iqtibos
    ABI

  7. A plant‐derived edible vaccine against hepatitis B virus

    Józef Kapusta, A. Modelska, Magdalena Figlerowicz +7

    Maqola19993 iqtibos
    ABI

  8. Edible Vaccines: Promises and Challenges

    Vrinda M Kurup, Jaya Thomas

    Sharh maqolaOchiq kirish20193 iqtibos
    ABI

  9. An edible vaccine development for coronavirus disease 2019: the concept

    Sayed Sartaj Sohrab

    Sharh maqolaOchiq kirish20203 iqtibos
    ABI

  10. Novel Transgenic Rice-Based Vaccines

    Tatsuhiko Azegami, Hiroshi Itoh, Hiroshi Kiyono +1

    Sharh maqolaOchiq kirish20142 iqtibos
    ABI

  11. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination

    Tomonori Nochi, Hidenori Takagi, Yoshikazu Yuki +11

    MaqolaOchiq kirish20072 iqtibos
    ABI

  12. Severe acute respiratory syndrome (SARS) S protein production in plants: Development of recombinant vaccine

    Natalia Pogrebnyak, Maxim Golovkin, V. M. Andrianov +4

    MaqolaOchiq kirish20052 iqtibos
    ABI

  13. Chloroplast‐derived vaccines against human diseases: achievements, challenges and scopes

    Andreas Günter Lössl, Mohammad Tahir Waheed

    Sharh maqola20112 iqtibos
    ABI

  14. Current state and challenges in developing oral vaccines

    Julia E. Vela Ramirez, Lindsey A. Sharpe, Nicholas A. Peppas

    Sharh maqolaOchiq kirish20172 iqtibos
    ABI

  15. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction

    Chee Wah Tan, Wan Ni Chia, Xijian Qin +13

    MaqolaOchiq kirish20202 iqtibos
    ABI

  16. Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates

    Konlavat Siriwattananon, Suwimon Manopwisedjaroen, Balamurugan Shanmugaraj +17

    MaqolaOchiq kirish20212 iqtibos
    ABI

  17. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape

    John S. Tregoning, Katie E. Flight, Sophie L. Higham +2

    Sharh maqolaOchiq kirish20212 iqtibos
    ABI

  18. Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy

    Dennis Christensen, Charlotta Polacek, Daniel J. Sheward +17

    MaqolaOchiq kirish20222 iqtibos
    ABI

  19. Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic

    Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova +3

    Sharh maqolaOchiq kirish20222 iqtibos
    ABI